江苏吴中(600200) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥433,183,662.96, representing a year-on-year increase of 19.79%[7] - The net profit attributable to shareholders for Q3 2021 was -¥20,214,303.68, showing a year-on-year increase of 26.10%[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥31,411,778.89, a decrease of 19.82% compared to the same period last year[7] - Total revenue for the first three quarters of 2021 was RMB 1,467,782,116.49, a decrease of 0.08% compared to RMB 1,480,902,752.55 in the same period of 2020[29] - The company reported a net loss of RMB 285,970,839.39 for the first three quarters of 2021, an improvement from a loss of RMB 335,359,552.83 in the same period of 2020[29] - Total revenue for Q3 2021 was 61,630,273.78, a significant recovery from a loss of 43,895,401.68 in Q3 2020[36] - Net profit for Q3 2021 reached 47,910,931.43, compared to a net loss of 46,885,237.77 in the same period last year[36] - The company reported a total comprehensive income of 32,796,452.79 for Q3 2021, compared to a loss of 46,885,237.77 in Q3 2020[36] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was ¥291,744,712.10, reflecting a significant increase of 393.79%[10] - Cash flow from operating activities for the first nine months of 2021 was 291,744,712.10, a recovery from a negative cash flow of -99,303,646.06 in the same period last year[38] - Cash inflow from investment activities totaled $207,719,660.60, a significant increase from $80,779,263.04[41] - Cash outflow from investment activities amounted to $198,894,773.23, compared to $69,751,376.20 in the previous period[41] - Net cash flow from investment activities was $8,824,887.37, down from $11,027,886.84[41] - Cash inflow from financing activities reached $1,208,990,674.64, compared to $1,436,656,652.08 previously[41] - Cash outflow from financing activities was $1,097,372,527.19, slightly higher than $1,046,497,726.24 last period[41] - Net cash flow from financing activities was $111,618,147.45, a decrease from $390,158,925.84[41] - The net increase in cash and cash equivalents was $412,184,763.79, compared to $301,881,300.89 previously[41] - The ending balance of cash and cash equivalents was $1,057,795,264.03, up from $890,495,959.37[41] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,864,695,658.79, an increase of 4.35% compared to the end of the previous year[10] - As of September 30, 2021, current assets totaled RMB 2,801,549,643.26, an increase of 4.52% from RMB 2,680,113,063.65 at the end of 2020[24] - Total liabilities as of September 30, 2021, were RMB 1,967,558,613.96, compared to RMB 1,851,875,953.69 at the end of 2020, reflecting an increase of 6.25%[29] - The total assets as of September 30, 2021, were RMB 3,864,695,658.79, up from RMB 3,703,715,674.65 at the end of 2020, indicating an increase of 4.34%[29] Shareholder Information - The equity attributable to shareholders at the end of the reporting period was ¥1,882,124,551.14, up 1.85% from the end of the previous year[10] - The company had a total of 85,650 common shareholders at the end of the reporting period[17] Research and Development - Research and development expenses increased to 18,244,320.92, up from 13,975,268.79 in Q3 2020, indicating a focus on innovation[36] - Government subsidies recognized during the reporting period amounted to ¥12,293,635.05, primarily related to drug research and development[10] Other Income and Expenses - Other income for Q3 2021 was 16,849,123.10, significantly higher than 8,318,607.63 in Q3 2020, indicating improved financial performance[32] - Sales expenses decreased to 323,378,635.79 from 341,694,207.32 in Q3 2020, reflecting cost management efforts[32] - Total operating costs for Q3 2021 were 1,543,593,828.16, slightly down from 1,548,280,482.83 in Q3 2020[32] Asset Disposal and Compensation - The company recognized asset disposal gains from the completion of relocation procedures for its subsidiary, contributing to the significant increase in net profit[13] - The company received a total of RMB 384,555,277.93 in compensation from the Jiangsu Xiangshui Ecological Chemical Park Management Committee[21] - The company has received RMB 125,034,345.93 in exit compensation as of the report date[21] Investments - Long-term equity investments increased to RMB 489,915,297.50 from RMB 394,923,331.51, showing a growth of 24.06%[24] - Cash received from other investment activities was $190,030,009.24, significantly higher than $40,000,000.00[41] - Cash paid for investments totaled $95,000,000.00, compared to $10,000,000.00 in the previous period[41]